Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
9.08M
-
Shares change
-
-432K
-
Total reported value, excl. options
-
$81.7M
-
Value change
-
-$4.15M
-
Put/Call ratio
-
0.08
-
Number of buys
-
17
-
Number of sells
-
-19
-
Price
-
$9.00
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q1 2022
53 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q1 2022.
Profound Medical Corp. - Common Shares (PROF) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.08M shares
of 29.9M outstanding shares and own 30.39% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.71M shares), GAGNON SECURITIES LLC (1.32M shares), LETKO, BROSSEAU & ASSOCIATES INC (1.3M shares), FIL Ltd (1.07M shares), Timelo Investment Management Inc. (778K shares), ROYCE & ASSOCIATES LP (505K shares), Gagnon Advisors, LLC (441K shares), AWM Investment Company, Inc. (349K shares), Blackcrane Capital, LLC (255K shares), and Zweig-DiMenna Associates LLC (242K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.